• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性调节性T细胞通过诱导上皮-间质转化促进肝癌细胞的侵袭性。

Infiltrating regulatory T cells promote invasiveness of liver cancer cells via inducing epithelial-mesenchymal transition.

作者信息

Huang Ai-Hua, Wang Hong-Bo, Wu Zhi-Feng, Wang Yi-Hong, Hu Bo, Jiang Zhi-Nong, Jin Mei, Wang Lin-Bo, Gao Ya-Bo

机构信息

Department of Pathology, Sir Run Run Shaw Hospital, Zhejiang University College of Medicine, Hangzhou 310016, China.

Department of General Surgery, Xiangyang Central Hospital, Hubei University of Arts and Science, Xiangyang 441053, China.

出版信息

Transl Cancer Res. 2019 Oct;8(6):2405-2415. doi: 10.21037/tcr.2019.09.54.

DOI:10.21037/tcr.2019.09.54
PMID:35116993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8797764/
Abstract

BACKGROUND

Regulatory T (Treg) cells are a major component of the microenvironment of hepatocellular carcinoma (HCC) contributing to immunosuppression. The present study aimed to evaluate the effects of Treg cells on the invasion potential of HCC.

METHODS

Infiltrating Treg cells were isolated from fresh HCC tissues by immunomagnetic bead separation and detected by flow cytometry. Circulating tumor cells (CTCs) were detected using the CellSearch platform. The cell migration and invasion potentials were evaluated by Transwell assays. The cell viability was tested by the cell counting kit-8 (CCK8) approach, and the apoptosis rates were determined by flow cytometry. The concentrations of active transforming growth factor-β1 (TGFβ1) were measured by enzyme-linked immunosorbent assay.

RESULTS

Infiltrating Treg cells significantly correlated with the number of CTCs and vascular invasion (both P<0.05). Moreover, these cells could greatly promote HCC migration, invasion, and proliferation, and inhibit HCC apoptosis. Polymerase chain reaction and Western blot assays revealed that Treg cells significantly decreased the expression levels of epithelium-related molecules and increased the expression levels of mesenchyme-related molecules. Treg cells could activate Smad2/3 via secreting TGFβ1, and these effects could be impaired by knocking down the expression of TGFβ1 in Treg cells.

CONCLUSIONS

The involvement of infiltrating Treg cells in triggering the TGFβ1 signaling pathway and promoting the epithelial-mesenchymal transition (EMT) of cancer cells during tumor hematogenous dissemination is presumably responsible for increasing the invasiveness potential of HCC cells. Targeting Treg cells in microenvironments can be a promising therapeutic strategy to improve the prognosis for patients with HCC undergoing resection.

摘要

背景

调节性T(Treg)细胞是肝细胞癌(HCC)微环境的主要组成部分,有助于免疫抑制。本研究旨在评估Treg细胞对HCC侵袭潜能的影响。

方法

通过免疫磁珠分离从新鲜HCC组织中分离浸润性Treg细胞,并通过流式细胞术进行检测。使用CellSearch平台检测循环肿瘤细胞(CTC)。通过Transwell试验评估细胞迁移和侵袭潜能。采用细胞计数试剂盒-8(CCK8)法检测细胞活力,通过流式细胞术测定凋亡率。采用酶联免疫吸附测定法测量活性转化生长因子-β1(TGFβ1)的浓度。

结果

浸润性Treg细胞与CTC数量和血管侵犯显著相关(均P<0.05)。此外,这些细胞可极大地促进HCC迁移、侵袭和增殖,并抑制HCC凋亡。聚合酶链反应和蛋白质印迹分析显示,Treg细胞显著降低上皮相关分子的表达水平,并增加间充质相关分子的表达水平。Treg细胞可通过分泌TGFβ1激活Smad2/3,而在Treg细胞中敲低TGFβ1的表达可削弱这些作用。

结论

浸润性Treg细胞在肿瘤血行播散过程中参与触发TGFβ1信号通路并促进癌细胞上皮-间质转化(EMT),可能是导致HCC细胞侵袭潜能增加的原因。针对微环境中的Treg细胞可能是改善接受切除术的HCC患者预后的一种有前景的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/3034b492211b/tcr-08-06-2405-fS.1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/4cbd18088fb4/tcr-08-06-2405-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/4ba2f8f2751e/tcr-08-06-2405-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/40365d87a910/tcr-08-06-2405-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/ddab3dafc242/tcr-08-06-2405-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/25c30fc48d3a/tcr-08-06-2405-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/3034b492211b/tcr-08-06-2405-fS.1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/4cbd18088fb4/tcr-08-06-2405-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/4ba2f8f2751e/tcr-08-06-2405-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/40365d87a910/tcr-08-06-2405-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/ddab3dafc242/tcr-08-06-2405-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/25c30fc48d3a/tcr-08-06-2405-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a8e/8797764/3034b492211b/tcr-08-06-2405-fS.1.jpg

相似文献

1
Infiltrating regulatory T cells promote invasiveness of liver cancer cells via inducing epithelial-mesenchymal transition.浸润性调节性T细胞通过诱导上皮-间质转化促进肝癌细胞的侵袭性。
Transl Cancer Res. 2019 Oct;8(6):2405-2415. doi: 10.21037/tcr.2019.09.54.
2
Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.转录因子特异性蛋白 1 介导丝氨酸/苏氨酸激酶 39 的上调通过激活转化生长因子-β1/Smad2/3 通路促进肝癌细胞的增殖、迁移、侵袭和上皮-间充质转化。
Bioengineered. 2021 Dec;12(1):3566-3577. doi: 10.1080/21655979.2021.1947939.
3
GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.GP73 通过激活 TGF-β1/Smad2 信号通路促进肝癌细胞的上皮间质转化和侵袭。
Carcinogenesis. 2018 Jul 3;39(7):900-910. doi: 10.1093/carcin/bgy010.
4
AZGP1 suppresses epithelial-to-mesenchymal transition and hepatic carcinogenesis by blocking TGFβ1-ERK2 pathways.AZGP1通过阻断TGFβ1-ERK2信号通路抑制上皮-间质转化和肝癌发生。
Cancer Lett. 2016 May 1;374(2):241-9. doi: 10.1016/j.canlet.2016.02.025. Epub 2016 Feb 20.
5
miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.miR-300 通过靶向 FAK/PI3K/AKT 信号通路调节肝癌的上皮-间充质转化和侵袭。
Biomed Pharmacother. 2018 Jul;103:1632-1642. doi: 10.1016/j.biopha.2018.03.005. Epub 2018 May 7.
6
MEF2 transcription factors promotes EMT and invasiveness of hepatocellular carcinoma through TGF-β1 autoregulation circuitry.MEF2转录因子通过TGF-β1自调节回路促进肝细胞癌的上皮-间质转化和侵袭性。
Tumour Biol. 2014 Nov;35(11):10943-51. doi: 10.1007/s13277-014-2403-1. Epub 2014 Aug 3.
7
Immune checkpoint molecules are regulated by transforming growth factor (TGF)-1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.免疫检查点分子受转化生长因子 (TGF)-1 诱导的肝癌上皮间质转化调节。
Int J Med Sci. 2021 Apr 22;18(12):2466-2479. doi: 10.7150/ijms.54239. eCollection 2021.
8
Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway.紫草素通过调节 miR-106b/SMAD7/TGF-β 信号通路抑制肝癌(HCC)细胞的进展和上皮-间充质转化。
Cell Biol Int. 2020 Feb;44(2):467-476. doi: 10.1002/cbin.11247. Epub 2019 Nov 4.
9
DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma.DEPTOR 通过自分泌 TGFβ1 信号诱导部分上皮间质转化和转移,并与肝细胞癌的不良预后相关。
J Exp Clin Cancer Res. 2019 Jun 22;38(1):273. doi: 10.1186/s13046-019-1220-1.
10
Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.在不同疾病阶段的肝癌患者的循环肿瘤细胞中表达的上皮-间充质转化标志物。
Cell Death Dis. 2013 Oct 3;4(10):e831. doi: 10.1038/cddis.2013.347.

引用本文的文献

1
Progression to fibrosis and hepatocellular carcinoma in DEN CCl liver mice, is associated with macrophage and striking regulatory T cells infiltration.在二乙基亚硝胺(DEN)-四氯化碳(CCl)诱导的肝纤维化小鼠模型中,向纤维化和肝细胞癌的进展与巨噬细胞及显著的调节性T细胞浸润有关。
Front Immunol. 2025 Jul 8;16:1601215. doi: 10.3389/fimmu.2025.1601215. eCollection 2025.
2
The Immunomodulatory Role of Vitamin D in Regulating the Th17/Treg Balance and Epithelial-Mesenchymal Transition: A Hypothesis for Gallbladder Cancer.维生素D在调节Th17/Treg平衡及上皮-间质转化中的免疫调节作用:胆囊癌的一种假说
Nutrients. 2024 Nov 29;16(23):4134. doi: 10.3390/nu16234134.
3

本文引用的文献

1
MicroRNA-663 induces immune dysregulation by inhibiting TGF-β1 production in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.微小 RNA-663 通过抑制系统性红斑狼疮患者骨髓间充质干细胞产生 TGF-β1 诱导免疫失调。
Cell Mol Immunol. 2019 Mar;16(3):260-274. doi: 10.1038/cmi.2018.1. Epub 2018 Mar 26.
2
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.血清膜联蛋白 A3 在肝细胞癌患者的诊断、预后预测和治疗反应评估中的应用。
Ann Surg Oncol. 2018 Jun;25(6):1686-1694. doi: 10.1245/s10434-018-6402-0. Epub 2018 Apr 6.
3
Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination.
乳腺癌干细胞通过分泌转化生长因子β产生免疫抑制性调节性T细胞,以逃避免疫清除。
Discov Oncol. 2023 Dec 1;14(1):220. doi: 10.1007/s12672-023-00787-z.
4
Short-chain fatty acids in cancer pathogenesis.短链脂肪酸在癌症发病机制中的作用。
Cancer Metastasis Rev. 2023 Sep;42(3):677-698. doi: 10.1007/s10555-023-10117-y. Epub 2023 Jul 11.
5
Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma.泛素-蛋白酶体系统介导的泛素化修饰模式及低级别胶质瘤肿瘤微环境浸润、干性和细胞衰老特征。
Aging (Albany NY). 2023 Apr 11;15(8):2970-2998. doi: 10.18632/aging.204650.
6
DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma.DDX1 是一个预后生物标志物,与肝细胞癌中的免疫浸润相关。
BMC Immunol. 2022 Nov 30;23(1):59. doi: 10.1186/s12865-022-00533-0.
7
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses.小细胞外囊泡是人类致癌病毒引发癌症发展的关键因素。
Infect Agent Cancer. 2022 Nov 28;17(1):58. doi: 10.1186/s13027-022-00471-x.
8
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors.一种基于外周血淋巴细胞亚群的列线图模型,用于评估接受免疫检查点抑制剂治疗的非小细胞肺癌患者的预后。
Transl Lung Cancer Res. 2021 Dec;10(12):4511-4525. doi: 10.21037/tlcr-21-899.
9
Role of hydrogen sulfide donors in cancer development and progression.硫化氢供体在癌症发展和进展中的作用。
Int J Biol Sci. 2021 Jan 1;17(1):73-88. doi: 10.7150/ijbs.47850. eCollection 2021.
Alternative Splicing of Controls Regulatory T Cell Effector Functions and Is Associated With Human Atherosclerotic Plaque Stability.
可变剪接调控调节性 T 细胞效应功能,并与人类动脉粥样硬化斑块稳定性相关。
Circ Res. 2018 May 11;122(10):1385-1394. doi: 10.1161/CIRCRESAHA.117.312340. Epub 2018 Apr 4.
4
CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.CADM2 作为 miR-10b 的一个新靶点,通过 FAK/AKT 通路促进肝癌的肿瘤转移。
J Exp Clin Cancer Res. 2018 Mar 5;37(1):46. doi: 10.1186/s13046-018-0699-1.
5
The role of molecular enrichment on future therapies in hepatocellular carcinoma.分子富集在肝细胞癌未来治疗中的作用。
J Hepatol. 2018 Jul;69(1):237-247. doi: 10.1016/j.jhep.2018.02.016. Epub 2018 Mar 2.
6
Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development.通过抑制剂 API-1 靶向 Pin1 调节 microRNA 生物发生并抑制肝细胞癌发展。
Hepatology. 2018 Aug;68(2):547-560. doi: 10.1002/hep.29819. Epub 2018 May 21.
7
The immunology of hepatocellular carcinoma.肝细胞癌的免疫学。
Nat Immunol. 2018 Mar;19(3):222-232. doi: 10.1038/s41590-018-0044-z. Epub 2018 Jan 29.
8
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.循环肿瘤细胞具有干细胞样表型,可用于肝癌的诊断、预后和治疗反应评估。
Clin Cancer Res. 2018 May 1;24(9):2203-2213. doi: 10.1158/1078-0432.CCR-17-1753. Epub 2018 Jan 26.
9
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.非编码 RNA 在肝细胞癌中的作用:分子功能与病理意义。
Nat Rev Gastroenterol Hepatol. 2018 Mar;15(3):137-151. doi: 10.1038/nrgastro.2017.169. Epub 2018 Jan 10.
10
Immunotherapy of Hepatocellular Carcinoma: Facts and Hopes.肝细胞癌的免疫治疗:现状与展望。
Clin Cancer Res. 2018 Apr 1;24(7):1518-1524. doi: 10.1158/1078-0432.CCR-17-0289. Epub 2017 Nov 14.